Related Experiment Video
Updated: Jun 28, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Identification of Determinants that Allow Maintenance of High-Level Fluoroquinolone Resistance in Acinetobacter
Efrat Hamami1, Wenwen Huo1, Juan Hernandez-Bird1
1Department of Molecular Biology and Microbiology, Tufts University School of Medicine, 150 Harrison Ave., Boston, MA 02111, USA.
Abstract:
Acinetobacter baumannii is associated with multidrug resistant (MDR) infections in healthcare settings, with fluoroquinolones such as ciprofloxacin being currently ineffective. Clinical isolates largely harbor mutations in the GyrA and TopoIV fluoroquinolone targets, as well as mutations that increase expression of drug resistance-nodulation-division (RND) efflux pumps. Factors critical for maintaining fitness levels of pump overproducers are uncharacterized despite their prevalence in clinical isolates. We here identify proteins that contribute to the fitness of FQR strains overexpressing three known RND systems using high-density insertion mutagenesis. Overexpression of the AdeFGH efflux pump caused hypersensitization to defects in outer membrane homeostatic regulation, including lesions that reduced LOS biosynthesis and blocked production of the major A. baumannii porin. In contrast, AdeAB pump hyperexpression, in the absence of elevated adeC expression (the outer membrane component of the pump), was relatively tolerant to loss of these functions, consistent with the outer membrane protein being the primary disruptive component. Surprisingly, overexpression of proton-transporting efflux pumps had little impact on cytosolic pH, consistent with a compensatory response to pump activity. The most striking transcriptional changes were associated with AdeFGH pump overexpression, including the activation of the phenylacetate (PAA) degradation regulon. Disruption of the PAA pathway resulted in cytosolic acidification and defective expression of genes involved in protection from oxidative stress. These results indicate that RND efflux pump overproduction is compensated by maintenance of outer membrane integrity in A. baumannii to facilitate fitness of FQR isolates.
Insights
Multidrug resistant Acinetobacter baumannii maintains fitness through efflux pump overproduction. Compensatory mechanisms, like outer membrane integrity, are crucial for fluoroquinolone-resistant strains.
Area of Science:
- Microbiology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Acinetobacter baumannii is a major cause of healthcare-associated infections.
- Multidrug resistance (MDR) and fluoroquinolone resistance are significant clinical challenges.
- Mutations in drug targets and increased efflux pump expression contribute to resistance.
Purpose of the Study:
- To identify factors essential for the fitness of fluoroquinolone-resistant (FQR) Acinetobacter baumannii strains overexpressing RND efflux pumps.
- To understand the compensatory mechanisms that enable these resistant strains to thrive.
Main Methods:
- High-density insertion mutagenesis was employed to screen for fitness-conferring genes.
- Analysis of gene expression changes, particularly transcriptional alterations.
- Assessment of cellular responses to efflux pump overexpression, including outer membrane integrity and cytosolic pH.
Main Results:
- Overexpression of the AdeFGH efflux pump sensitized strains to defects in outer membrane homeostasis.
- AdeAB pump hyperexpression showed tolerance to outer membrane disruptions.
- Phenylacetate (PAA) degradation pathway activation was observed with AdeFGH overexpression, impacting oxidative stress response.
Conclusions:
- Outer membrane integrity maintenance is critical for the fitness of Acinetobacter baumannii strains overproducing RND efflux pumps.
- Efflux pump overproduction is compensated by cellular mechanisms to ensure bacterial survival and proliferation.
- Understanding these fitness factors is key to developing strategies against MDR infections.

